Michael P. Stehn

Corporate Officer/Principal en Parenteral Drug Association .

Health Technology

Consumer Services

Cargos activos de Michael P. Stehn

Empresas	Cargo	Inicio	Fin
Parenteral Drug Association	Corporate Officer/Principal	-	-

Empresas	Cargo	Inicio	Fin
AKORN, INC.	Director de Operaciones	01/01/1990	05/09/2012
AKORN, INC.	Corporate Officer/Principal	05/09/2012	01/02/2020
The Rugby Group, Inc. The Rugby Group, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., The Rugby Group, Inc. is a company that develops and manufactures generic drugs. The company is based in Parsippany, NJ. The Rugby Group was acquired by Actavis, Inc. from Hoechst AG on August 26, 1997 for $70 million.	Corporate Officer/Principal	-	-

Fairleigh Dickinson University

Undergraduate Degree

Internacional

Estados Unidos

Operativa

Corporate Officer/Principal	3
Chief Operating Officer	1
Undergraduate Degree	1

Sectorial

Health Technology	3
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	3
Akorn, Inc. Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL.	Health Technology
The Rugby Group, Inc. The Rugby Group, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., The Rugby Group, Inc. is a company that develops and manufactures generic drugs. The company is based in Parsippany, NJ. The Rugby Group was acquired by Actavis, Inc. from Hoechst AG on August 26, 1997 for $70 million.	Health Technology
Parenteral Drug Association